Ledbetter J A, Martin P J, Spooner C E, Wofsy D, Tsu T T, Beatty P G, Gladstone P
J Immunol. 1985 Oct;135(4):2331-6.
We have shown previously that binding of a monoclonal antibody (MAb) to Tp44 molecules increased the proliferation of anti-CD3-activated T cells by causing enhanced IL 2 receptor expression and IL 2 release. We now show that anti-CD5 (Tp67) antibodies have a similar effect under conditions in which monocytes are suboptimally activated or where monocytes are not present. The activity did not depend on antibody isotype or on the precise CD5 epitope recognized. Functional experiments indicated that both IL 2 production and IL 2 receptor expression were enhanced by antibody binding. Anti-Tp67 and anti-Tp44 appear to augment proliferation through distinct mechanisms, because both antibodies together had greater activity than either antibody alone. In neither system is the Fc portion of the antibody required, because F(ab')2 fragments had activity equivalent to that of the intact antibody and were effective at concentrations as low as 10 ng/ml. Fab fragments of anti-Tp67 were active, but Fab fragments of anti-Tp44 had no effect. Anti-Tp67 and anti-Tp44 were able to sustain continuous proliferation of anti-CD3-Sepharose-stimulated T cells for up to 2.5 wk without exogenous IL 2 or feeder cells. These experiments suggest that Tp67 and Tp44 are receptors that play a critical regulatory role in the control of T cell proliferation.
我们先前已表明,单克隆抗体(MAb)与Tp44分子结合可通过增强白细胞介素2(IL 2)受体表达和IL 2释放来增加抗CD3激活的T细胞增殖。我们现在表明,在单核细胞未充分激活或不存在单核细胞的条件下,抗CD5(Tp67)抗体具有类似作用。该活性不依赖于抗体的同种型或所识别的精确CD5表位。功能实验表明,抗体结合可增强IL 2的产生和IL 2受体的表达。抗Tp67和抗Tp44似乎通过不同机制增强增殖,因为两种抗体共同作用时比单独任何一种抗体的活性都更强。在这两个系统中,均不需要抗体的Fc部分,因为F(ab')2片段具有与完整抗体相当的活性,并且在低至10 ng/ml的浓度下也有效。抗Tp67的Fab片段具有活性,但抗Tp44的Fab片段无作用。抗Tp67和抗Tp44能够在无外源性IL 2或饲养细胞的情况下,使抗CD3 - 琼脂糖珠刺激的T细胞持续增殖长达2.5周。这些实验表明,Tp67和Tp44是在T细胞增殖控制中起关键调节作用的受体。